Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: A proteomic approach

Clinica Chimica Acta

Volumn 400, Issue 1-2, 2009, Pages 14-20

  Sinha, Ashima ^a   Srivastava, Nalini ^b   Singh, Seema ^a   Singh, Anand Kumar ^a   Bhushan, Shashi ^c   Shukla, Rakesh ^c   Singh, Mahendra Pratap ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b JIWAJI UNIVERSITY   (India)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cerebrospinal fluid; Parkinson's disease; Proteomics

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN BETA FRAGMENT; MUTANT GLOBIN; PROLINE RICH REPEAT 14; SERUM ALBUMIN CHAIN A; SERUM ALBUMIN PRECURSOR; SERUM TRANSFERRIN N TERMINAL LOBE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; ISOELECTRIC FOCUSING; MALE; MASS SPECTROMETRY; NERVE DEGENERATION; PARKINSON DISEASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECURSOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; CASE-CONTROL STUDIES; CEREBROSPINAL FLUID PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PARKINSON DISEASE; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 57949085678     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.09.026     Document Type: Article

References (29)

1. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22 (1999) 123-144
2. Singh M.P., Patel S., Dikshit M., and Gupta Y.K. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease. Indian J Biochem Biophys 43 (2006) 69-81
3. Patel S., Sinha A., and Singh M.P. Identification of differentially expressed proteins in striatum of maneb-and paraquat-induced Parkinson's disease phenotype in mouse. Neurotoxicol Teratol 29 (2007) 578-585
4. Morrison R.S., Kinoshita Y., Johnson M.D., et al. Proteomic analysis in the neurosciences. Mol Cell Proteomics 1 (2002) 553-560
5. Aebersold R., and Mann M. Mass spectrometry-based proteomics. Nature 422 (2003) 198-207
6. Hanash S. Disease proteomics. Nature 422 (2003) 226-232
7. Sinha A., Singh C., Parmar D., and Singh M.P. Proteomics in clinical interventions: achievements and limitations in biomarker development. Life Sci 80 (2007) 1345-1354
8. Sinha A., Patel S., Shukla R., and Singh M.P. Blood proteome profiling in case controls and Parkinson's disease patients in Indian population. Clin Chim Acta 380 (2007) 232-234
9. Finehout E.J., Franck Z., Choe L.H., Relkin N., and Lee K.H. Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann Neurol 61 (2007) 120-129
10. Davidsson P., and Sjögren M. Proteome studies of CSF in AD patients. Mech Ageing Dev 127 (2006) 133-137
11. Blennow K., Wallin A., and Häger O. Low frequency of post-lumbar puncture headache in demented patients. Acta Neurol Scand 88 (1993) 221-223
12. Puchades M., Hansson S.F., Nilsson C.L., Andreasen N., Blennow K., and Davidsson P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res 118 (2003) 140-146
13. Raymackers J., Daniels A., De Brabandere V., et al. Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix assisted laser desorption/ionization mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry. Electrophoresis 21 (2000) 2266-2283
14. Sickmann A., Dormeyer W., Wortelkamp S., Woitalla D., Kuhn W., and Meyer H.E. Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 21 (2000) 2721-2728
15. Yuan X., Russell T., Wood G., and Desiderio D.M. Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis 23 (2002) 1185-1196
16. Waragai M., Wei J., Fujita M., et al. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochem Biophys Res Commun 345 (2006) 967-972
17. Tokuda T., Salem S.A., Allsop D., et al. Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease. Biochem Biophys Res Commun 349 (2006) 162-166
18. Calne D.B., Snow B.J., and Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 32 (1992) S125-127
19. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
21. Singh S., Singh K., Patel S., et al. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse. Brain Res 1207 (2008) 193-207
22. Sheta E.A., Appel S.H., and Goldknopf I.L. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases. Expert Rev Proteomics 3 (2006) 45-62
23. Michell A.W., Lewis S.J., Foltynie T., and Barker R.A. Biomarkers and Parkinson's disease. Brain 127 (2004) 1693-1705
24. Lopez M.F., Berggren K., Chernokalskaya E., Lazarev A., Robinson M., and Patton W.F. A comparison of silver stain and SYPRO Ruby protein gel stain with respect to protein detection in two-dimensional gels and identification by peptide mass profiling. Electrophoresis 21 (2000) 3673-3683
25. Gorg A., Obermaier C., Boguth G., et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21 (2000) 1037-1053
26. Martins de Souza D., Oliveira B.M., Castro-Dias E., et al. The untiring search for the most complete proteome representation: reviewing the methods. Brief Funct Genomic Proteomic 7 (2008) 312-321
27. Haugen M.H., Flatmark K., Mikalsen S.O., and Malandsmo G.M. The metastasis-associated protein S100A4 exists in several charged variants suggesting the presence of posttranslational modifications. BMC Cancer 8 (2008) 172
28. Liu C., Chen Y., Yu X., et al. Proteomic analysis of differential proteins in pancreatic carcinomas: effects of MBD1 knockdown by stable RNA interference. BMC Cancer 8 (2008) 121
29. Zhang K., Wrzesinski K., Fey S.J., Mose Larsen P., Zhang X., and Roepstorff P. Assessing CMT cell line stability by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry based proteome analysis. J Proteomics 71 (2008) 160-167